Latest News
Latest News
Naltrexone is safe and beneficial in AUD with cirrhosis
VIENNA –
Latest News
WHO declares aspartame as possible carcinogen
“In short the evidence that aspartame causes primary liver cancer, or any other cancer in humans, is very weak.”
Latest News
Impostor syndrome is a risk for doctors of all ages
These people ignore praise, are highly self-critical, and attribute their successes to external factors, such as luck, hard work, or receiving...
From the Journals
One type of bariatric surgery betters IBD outcomes
Previous studies have shown that bariatric surgery is safe for people with IBD, but there have been few long-term data on whether the weight loss...
Latest News
LAMA-LABA surpasses corticosteroid combination as COPD therapy
Large matched cohort study suggests stronger safety and effectiveness outcomes with LAMA-LABA inhalers vs. ICS-LABA inhalers.
From the Journals
Fibromyalgia linked to higher mortality risk
Fibromyalgia was linked to a 27% greater risk of death from all causes in a systematic review and meta-analysis of eight studies published from...
From the Journals
Antidrug antibody effects compared across RA biologics
The presence of antidrug antibodies was associated with a diminished response to biologic disease-modifying antirheumatic drugs in a prospective...
Feature
Can berberine live up to the claim that it’s ‘nature’s Ozempic’?
The National Center for Complementary and Integrative Health issued a warning...
From the Journals
New German guidelines change the paradigm for asthma
The guideline was created by the German Respiratory Society and a further 11 professional societies from Germany and Austria.
News from the FDA/CDC
FDA approves first over-the-counter birth control pill
The product, OPill, is expected to be available early in 2024.
News from the FDA/CDC
FDA approves new device for enlarged prostate treatment
The device improved urinary flow rate and decreased the amount of urine stored in the bladder following urination.